iShares Biotechnology ETF $IBB Stake Lifted by Rye Brook Capital LLC

Rye Brook Capital LLC raised its position in iShares Biotechnology ETF (NASDAQ:IBB) by 13.0% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 24,300 shares of the financial services provider’s stock after purchasing an additional 2,800 shares during the period. iShares Biotechnology ETF accounts for approximately 3.2% of Rye Brook Capital LLC’s portfolio, making the stock its 10th biggest holding. Rye Brook Capital LLC’s holdings in iShares Biotechnology ETF were worth $3,074,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ramirez Asset Management Inc. purchased a new position in iShares Biotechnology ETF in the 1st quarter valued at $26,000. Berkshire Money Management Inc. purchased a new position in iShares Biotechnology ETF in the 2nd quarter valued at $28,000. Financial Gravity Asset Management Inc. purchased a new position in iShares Biotechnology ETF in the 1st quarter valued at $30,000. Woodside Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the 1st quarter valued at $31,000. Finally, CX Institutional purchased a new position in iShares Biotechnology ETF in the 1st quarter valued at $32,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $151.99 on Thursday. The stock’s fifty day moving average is $140.21 and its two-hundred day moving average is $130.36. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $153.01.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 19th. Stockholders of record on Tuesday, September 16th were issued a dividend of $0.0828 per share. This represents a $0.33 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.